• SENSEX 73,123.83
    -125.56 (--0.17%)
  • BANKNIFTY 54,287.35
    -638.35 (--1.16%)
  • SBI
    950.75 900.80(%)
  • Tonbo Imaging
    1,209.85 1,209.85(%)
  • Cyient
    1,268.00 1,268.00(%)
  • NSE
    1,640.25 1,640.25(%)
  • Bonfiglioli Tran
    527.40 527.40(%)
  • IndusInd Bank
    831.35 750.45(%)
  • Eternal
    317.50 344.75(%)
  • JSW Energy
    440.25 428.00(%)
  • Voltas
    940.00 940.00(%)
  • Swiggy
    174.90 174.90(%)
  • Persistent Systems
    5,688.80 4,242.65(%)
  • Cupid
    302.45 45.40(%)
  • TCS
    2,624.75 3,336.70(%)
  • Infosys
    1,198.30 1,727.85(%)
  • Havells India
    1,003.65 1,003.65(%)
  • PC Jeweller
    17.08 7.45(%)
  • Bharat Forge
    1,680.45 1,265.00(%)
  • C P C L
    1,529.95 1,677.00(%)
  • Netweb Technol.
    4,238.00 2,942.45(%)
  • Lenskart Solut.
    615.80 355.70(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Medicamen Biotech Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5905.0
  • ISIN : INE646B01010
253.35 -12 (-4.45%)
  • As on 24 Oct 2026 (EOD)

  • Today’s Low

    251.90

  • Today’s High

    265.15

  • Open

    265.15

  • Perv Close

    265.15

  • 52W Low

    212.40

  • 52W High

    447.65

Key Indicators

  • P/E(TTM)

    33.43

  • Mar.Cap (₹Cr.)

    343.61

  • Div & Yield %

    0.39

  • Book Value(₹)

    199.90

  • Debt-Equity Ratio

    -4.45

  • AGM Date

    23-Oct-2026

  • EPS

    7.59

  • P/E Ratio

    33.43

Financials Ratios

  • Debt-Equity Ratio

    0.14

  • Mar.Cap (₹Cr.)

    343.61

  • RONW (%)

    4.74

  • ROCE (%)

    8.14

Score Board

  • Equity (₹ in Cr.)

    13.56

  • BV (₹)

    199.90

  • Sales( ₹ in Cr.)

    178.85

  • NP (in Cr.)

    9.41

  • NP Var(%)

    0.0

  • Div%

    10.0

  • CPS (₹)

    12.10

  • EPS (₹)

    6.90

  • Traded Value (₹ in Lakhs)

    344.16

  • 52 Week High

    447.65

  • 52 Week Low

    212.40

  • Price BSE

    254.0

  • Price NSE

    253.00

  • Market Capital( in Cr.)

    344.16

  • P/C Ratio

    20.90

  • P/E Ratio

    36.60

  • Price Vs.BV

    6.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 178.85 151.46 172.39 137.88 115.45 110.15
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 178.85 151.46 172.39 137.88 115.45 110.15
Other Income 3.10 6.23 2.30 2.46 1.72 0.75
Stock Adjustments -7.42 6.08 13.32 10.30 3.34 -1.04
Total Income 174.53 163.77 188.01 150.64 120.51 109.86
EXPENDITURE :            
Raw Materials 91.81 88.83 104.70 81.80 55.69 65.84
Power and Fuel Cost 8.05 6.94 7.12 5.67 5.86 2.68
Employee Cost 22.79 21.57 22.12 18.57 14.50 8.79
Other Manufacturing Expenses 14.23 10.87 10.24 8.70 9.60 7.37
Selling and Administration Expenses 13.91 11.01 12.42 6.65 7.50 3.94
Miscellaneous Expenses 1.20 1.21 1.87 2.18 1.52 0.46
Employee Benefit Expenses 22.79 21.57 22.12 18.57 14.50 8.79
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 151.98 140.43 158.47 123.56 94.69 89.08
Operating Profit 22.54 23.34 29.55 27.08 25.82 20.78
Interest 3.93 3.60 5.65 3.39 1.94 1.51
Gross Profit 18.61 19.74 23.90 23.69 23.88 19.27
Depreciation 7.06 6.96 7.01 6.35 5.77 2.52
Profit Before Tax 11.55 12.78 16.89 17.34 18.11 16.75
Current Tax 2.55 3.64 4.22 3.70 3.98 4.15
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.41 -0.31 -0.63 -1.37 -0.78 0.12
Reported Net Profit 9.41 9.45 13.30 15.00 14.91 12.49
Extraordinary Items 0.00 0.00 0.00 -0.01 0.00 0.00
Adjusted Net Profit 9.41 9.45 13.30 15.01 14.91 12.49
Adjustment below Net Profit 0.47 0.26 0.00 0.09 0.00 0.00
P & L Balance brought forward 102.61 94.18 82.15 68.32 54.43 42.56
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.36 1.27 1.27 1.27 1.22 0.61
P & L Balance carried down 111.13 102.61 94.18 82.15 68.12 54.43
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 10.00 10.00 10.00 10.00
Dividend Per Share(Rs) 1.00 1.00 1.00 1.00 1.00 1.00
Earnings Per Share-Unit Curr 6.94 7.43 10.46 11.86 12.20 10.22
Earnings Per Share(Adj)-Unit Curr 6.94 7.43 10.46 11.86 12.20 10.22
Book Value 199.90 171.17 164.54 152.30 121.18 109.98
Book Value(Adj)-Unit Curr 199.90 171.17 164.54 152.30 121.18 109.98

Shareholding Pattern

  • Promoter Group

    40.46%

  • Public Share Holding

    59.54%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 5,487,095 40.46 5,487,095 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,487,095 40.46 5,487,095 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 7,000 0.05 7,000 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 8,897 0.07 8,897 1
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 168 0.00 168 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 599,995 4.42 599,995 1
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 312 0.00 312 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 616,372 4.54 616,372 6
2] Non Institution
Bodies Corporate 280,209 2.07 278,709 100
Clearing Members 11,213 0.08 11,213 3
Directors of their Relatives 80,170 0.59 80,170 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 139,693 1.03 139,493 182
Foreign Non Institution Other 1,694,820 12.50 1,694,820 2
Hindu Undivided Families 386,111 2.85 386,111 369
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 896,599 6.61 896,599 21
Individuals holding nominal share capital up to Rs. 1 lakh 3,599,750 26.54 3,560,130 10,985
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 326,861 2.41 326,861 3
Sub Total 7,459,348 55.00 7,418,028 11,673
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 13,562,815 100.00 13,521,495 11,680

Company Background

Medicamen Biotech LtdPharmaceuticals - Indian - Formulations

  • Medicamen Biotech Ltd
  • BSE Code : 5905.0
  • ISIN : INE646B01010

  • Incorporation Year

    1993

  • Registered Office

    1506 Chiranjiv Tower 43
    Nehru Place, New Delhi,
    New Delhi-110019

  • Telephone

    91-11-47589500

  • FAX

    91-11-26213081

  • Chairman

    Rahul Bishnoi

  • Managing Director

  • Company Secretary

    Parul Choudhary

  • Auditor

    Rai Qimat & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Link Intime India Pvt Ltd
    Narang Tower,
    44 Community Centre,Naraina Ind Area
    Mumbai - New Delhi-110028

Medicamen Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Medicamen Biotec 253.75 181.95 178.85 33.43 5.46
Abbott India 25,004.30 7,217.19 6,929.05 32.91 43.78
Astrazeneca Phar 5,988.15 2,304.07 2,275.58 88.26 27.86
Glaxosmi. Pharma 2,404.80 3,932.76 3,790.20 38.42 58.17
Novartis India 1,834.75 393.10 354.33 46.33 15.94
Cipla 1,337.00 20,102.60 18,979.95 35.14 13.88
Bliss GVS Pharma 628.50 773.53 729.81 58.41 12.51
Amrutanjan Healt 487.65 520.13 502.55 26.12 24.16
Fermenta Biotec. 454.90 474.15 450.25 21.24 18.77
Guj. Themis Bio. 327.25 168.25 165.82 87.50 18.05
Ambalal Sarabhai 34.60 19.52 3.94 64.07 6.77